Navigation Links
Stemedica Announces Completion of Clinical Stem Cell Master Bank
Date:9/14/2010

SAN DIEGO, Sept. 14 /PRNewswire/ -- Stemedica Cell Technologies, Inc., a world leader in adult stem cell manufacturing and research, announced today that it has completed its proprietary master bank of mesenchymal bone marrow-derived stem cells. The master cell bank was manufactured in accordance with FDA Good Manufacturing Practices (cGMP). The cell bank has successfully passed all the necessary safety testing required by the FDA and is in compliance with the U.S. Code of Federal Regulations.  Stem cells from the master bank will be used to support clinical trials in the United States and worldwide. The master bank together with its parent bank has the capacity to treat up to 300,000 patients participating in approved clinical trials.

The master bank has been created at the Company's San Diego cGMP manufacturing facility, which is licensed by the State of California's Department of Public Health, Food and Drug Branch to produce stem cells, drugs and biologic products for human clinical trials.  Stem cells from the master bank will be used in the Company's current FDA-approved clinical trial for ischemic stroke in the United States.  There are over 750,000 strokes each year in the United States resulting in 160,000 deaths. In addition, there currently is no treatment option available for the thousands that are left with severe disabilities.

"Stemedica's stem cells will also be provided to sites in various countries that have already received regulatory approval to conduct clinical trials using Stemedica's products," stated, Nikolai Tankovich, MD, PhD, Stemedica's President and Chief Medical Officer. "We have a pending Investigational New Drug application to conduct a clinical trial outside the United States for vascular dementia, the most common form of dementia.  Alzheimer's represents a subgroup of this condition.  Researchers in the United States will now have access to Stemedica stem cells for preclinical studies; cell
'/>"/>

SOURCE Stemedica Cell Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Stemedica Announces the Appointment of Dr. Csar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
2. Stemedica Announces the Appointment of Dr. Lev Verkh as Chief Regulatory and Clinical Development Officer
3. Stemedica Completes Meeting with the FDA
4. United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy
5. The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. - First Clinical Trail Anticipated To Begin Early 2010
6. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
7. Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries
8. Stemedica Requests Pre-IND Meeting With FDA
9. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
10. Renowned Stem Cell Researcher Files Study Results With Stemedica
11. CIRM Completes Briefing Visit to Stemedica Cell Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... YARDLEY , Pennsylvanie, 18 septembre 2014 ... Lyon en 1974, a été ... à compléter les évaluations cliniques traditionnelles par ... Reported Outcomes) et sur les impacts économiques ... http://photos.prnewswire.com/prnh/20140618/119365 A cours ...
(Date:9/18/2014)... , Sept. 18, 2014   Sigma-Aldrich ... it has entered into a new gene editing ... School,s Vector Core. Under the partnership, Sigma-Aldrich will ... experimental design consultation, and dedicated gene editing bioinformaticians. ... gene editing-based research at the U-M Medical School. ...
(Date:9/18/2014)... September 18, 2014 OMICS Group ... globe to participate in the ‘Open Access Week’ ... to OMICS Group Pharma Journals from ... of the fastest emerging Sciences, accelerating with a ... services across the globe. The industry is gearing ...
(Date:9/18/2014)... MA (PRWEB) September 18, 2014 ... Molecule Sequencing (tSMS™) technology, announced today the closing ... of investment, led by Genomic Diagnostic Technologies, will ... and diagnostic applications. , Founded in March 2013 ... and Bioinformatics Analyst at Helicos BioSciences, SeqLL has ...
Breaking Biology Technology:1974 - 2014 - Mapi fête ses 40 ans 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 4Pharma and Omics Journals to Address Global Challenges during Open Access Week 2Pharma and Omics Journals to Address Global Challenges during Open Access Week 3SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing 2
... ROMAINVILLE, France, March 13 ,Cellectis SA (NYSE: ... rational genome engineering,has announced today that it ... Inc. in the United States District Court ... lawsuit seeks a declaration that,by making and ...
... pm ET today, BEDMINSTER, N.J., March 13 ... reported 2007 financial results,and accomplishments that reflected the ... late-stage product candidates in specialty,indications for gastrointestinal and ... line with its new business plan, during 2007 ...
... IV Patent Challenge Underway -, CORONA, Calif., ... ), a leading specialty pharmaceutical,company, today confirmed that ... with the U.S. Food and Drug Administration (FDA) ... tablets, USP,(0.09 mg/0.02 mg) extended-cycle oral contraceptive product ...
Cached Biology Technology:Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 2Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 3Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 4NPS Pharmaceuticals Reports 2007 Financial Results 2NPS Pharmaceuticals Reports 2007 Financial Results 3NPS Pharmaceuticals Reports 2007 Financial Results 4NPS Pharmaceuticals Reports 2007 Financial Results 5NPS Pharmaceuticals Reports 2007 Financial Results 6NPS Pharmaceuticals Reports 2007 Financial Results 7NPS Pharmaceuticals Reports 2007 Financial Results 8NPS Pharmaceuticals Reports 2007 Financial Results 9Watson Files FDA Application for Generic LYBREL(R) 2
(Date:9/18/2014)... it that when people are too stressed they are ... the Brain Mind Institute (BMI) at EPFL have just ... between chronic stress and the loss of social skills ... attacks a synaptic regulatory molecule in the brain. This ... Communications . , Carmen Sandi,s team went to ...
(Date:9/18/2014)... the ideal animal in which to study the genes ... into tens of thousands of freshwater streams and lakes ... adapt to the new environment. , Breeding studies between ... up one of the genes that controls tooth number, ... regulation in a freshwater population is associated with a ...
(Date:9/18/2014)... is probably the ultimate form of camouflage: you don,t ... this strategy is not as uncommon as you might ... County, USA, explains that the larval life stages of ... part of the anatomy that most creatures cannot make ... have to shield each individual eye unit with an ...
Breaking Biology News(10 mins):How stress tears us apart 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3Transparent larvae hide opaque eyes behind reflections 2
... a new biological pathway-based computational model, called the Pathway-based ... between different diseases as reported in BioDataMining ... present in large publicly available disease datasets to find ... a visual form. "The PHPN offers a bird,s ...
... 11 million people suffer severe burns. The resulting large, deep ... lifelong scars. What is needed to reduce this kind of ... very limited area of skin can be removed from the ... Besides conventional skin grafting, another option is to engineer a ...
... to finding cures for heart disease scientists are working to ... a tissue model for the human heart that can bridge ... exist for other organs, but for the heart, this has ... embryonic stem cells with the resulting muscle having significant similarities ...
Cached Biology News:Dartmouth researchers develop new tool to identify genetic risk factors 2Blood and lymphatic capillaries grown for the first time in the lab 2Scientists develop an engineered cardiac tissue model to study the human heart 2
... PCR Purification Kits provide rapid and efficient ... PCR products, and salts from PCR products ... provides two Binding Buffer options for ... can be performed in either single column ...
Mus musculus junctophilin 2 (Jph2) Antigen: Recombinant Protein...
... Cloning Kits for Sequencing allow 5-minute cloning and ... TOPO Cloning vectors with primer sites located as ... product insertion site. This minimizes the amount of ... reaching the sequence of your insert.vectors are available. ...
2.0 GHz Compaq Computer with 512 MB RAM, 32 MB AGP Graphics Card, 40 GB Hard Drive, 1 Serial Port & Open PCI Slot, Windows 2000 OS, MS Office, CD Read/Writer and 18 Flat Panel Monitor...
Biology Products: